Sally Hunsberger

Sally Hunsberger

UNVERIFIED PROFILE

Are you Sally Hunsberger?   Register this Author

Register author
Sally Hunsberger

Sally Hunsberger

Publications by authors named "Sally Hunsberger"

Are you Sally Hunsberger?   Register this Author

48Publications

675Reads

7Profile Views

Interim monitoring in a treatment strategy trial with a composite primary endpoint.

Contemp Clin Trials 2019 Sep 11;86:105846. Epub 2019 Sep 11.

School of Medicine, University of California, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cct.2019.105846DOI Listing
September 2019

Natural History and Evolution of Anti-Interferon-γ Autoantibody-Associated Immunodeficiency Syndrome in Thailand and the US.

Clin Infect Dis 2019 Aug 20. Epub 2019 Aug 20.

Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, US.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciz786DOI Listing
August 2019

Efficacy Analysis in Healthy-Volunteer Influenza Challenge Trials: Intention To Treat.

Antimicrob Agents Chemother 2018 01 21;62(1). Epub 2017 Dec 21.

LID Clinical Studies Unit, Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.02018-17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740326PMC
January 2018

Analysis of an ordinal endpoint for use in evaluating treatments for severe influenza requiring hospitalization.

Clin Trials 2017 Jun 6;14(3):264-276. Epub 2017 Mar 6.

1 Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1740774517697919DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528156PMC
June 2017

Approaches to retrospective sampling for longitudinal transition regression models.

Stat Interface 2014;7(1):75-85

Epidemiology Branch, 6100 Executive Blvd, Rockville, MD 20852, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4310/SII.2014.v7.n1.a9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882117PMC
January 2014

Response.

J Natl Cancer Inst 2013 Jul 30;105(13):993-4. Epub 2013 May 30.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt126DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708538PMC
July 2013

Meta-analysis of the relationship between dose and benefit in phase I targeted agent trials.

J Natl Cancer Inst 2012 Dec 19;104(24):1860-6. Epub 2012 Nov 19.

Karmanos Cancer Institute, Department of Oncology, Detroit, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djs439DOI Listing
December 2012

Integrated phase II/III clinical trials in oncology: a case study.

Clin Trials 2012 Dec 22;9(6):741-7. Epub 2012 Nov 22.

Department of Statistics, Radiation Therapy Oncology Group, American College of Radiology, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1740774512464724DOI Listing
December 2012

Expression of Gli1 in the hedgehog signaling pathway and breast cancer recurrence.

Chin J Cancer Res 2012 Dec;24(4):257-8

Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, USA.

View Article

Download full-text PDF

Source
http://www.cjcrcn.org/article/html_1107.html
Publisher Site
http://dx.doi.org/10.3978/j.issn.1000-9604.2012.09.07DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551324PMC
December 2012

Analysis of progression-free survival data using a discrete time survival model that incorporates measurements with and without diagnostic error.

Clin Trials 2010 Dec 25;7(6):634-42. Epub 2010 Nov 25.

National Cancer Institute, Biostatistics Research Branch, Rockville, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1740774510384887DOI Listing
December 2010

A comparison of phase II study strategies.

Clin Cancer Res 2009 Oct 29;15(19):5950-5. Epub 2009 Sep 29.

Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-3205DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757284PMC
October 2009

Physical activity, weight control, and breast cancer risk and survival: clinical trial rationale and design considerations.

J Natl Cancer Inst 2009 May 28;101(9):630-43. Epub 2009 Apr 28.

Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, EPN 4005, Executive Blvd, Bethesda, MD 20892-7344, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djp068DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2677576PMC
May 2009

A finite mixture survival model to characterize risk groups of neuroblastoma.

Stat Med 2009 Apr;28(8):1301-14

Biometric Research Branch, National Cancer Institute, 6130 Executive Boulevard, Rm 8120, Rockville, MD 20852, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/sim.3543DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559264PMC
April 2009

Effective incorporation of biomarkers into phase II trials.

Clin Cancer Res 2009 Mar 10;15(6):1898-905. Epub 2009 Mar 10.

Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://linus.nci.nih.gov/techreport/McShane_etal_CCR_2009_fi
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-08-2033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874890PMC
March 2009

Complexities in interpretation of osteosarcoma clinical trial results.

J Clin Oncol 2008 Jun;26(18):3103-4; author reply 3104-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.17.3484DOI Listing
June 2008

Testing logistic regression coefficients with clustered data and few positive outcomes.

Stat Med 2008 Apr;27(8):1305-24

Biometric Research Branch, National Cancer Institute, Bethesda, MD 20892, U.S.A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/sim.3011DOI Listing
April 2008

Proposal for the use of progression-free survival in unblinded randomized trials.

J Clin Oncol 2007 May;25(15):2122-6

Biometric Research Branch and the Clinical Investigations Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2006.09.6198
Publisher Site
http://dx.doi.org/10.1200/JCO.2006.09.6198DOI Listing
May 2007

Combining treatment selection and definitive testing.

Biom J 2006 Aug;48(4):690-2; discussion 693-6

Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, 6700A Rockledge Drive, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
August 2006

On analyzing circadian rhythms data using nonlinear mixed models with harmonic terms.

Biometrics 2005 Dec;61(4):1115-20; discussion 1120-2

Biometric Research Branch, National Cancer Institute, Executive Plaza North, Bethesda, Maryland 20892-7434, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.0006-341X.2005.464_1.xDOI Listing
December 2005

Design issues of randomized phase II trials and a proposal for phase II screening trials.

J Clin Oncol 2005 Oct;23(28):7199-206

Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2005.01.149
Publisher Site
http://dx.doi.org/10.1200/JCO.2005.01.149DOI Listing
October 2005

Preliminary data release for randomized clinical trials of noninferiority: a new proposal.

J Clin Oncol 2005 Aug 18;23(24):5831-6. Epub 2005 Jul 18.

Biometric Research Branch and Clinical Investigations Branch, Division of Cancer Treatment and Diagnosis, EPN-8128, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2005.02.105
Publisher Site
http://dx.doi.org/10.1200/JCO.2005.02.105DOI Listing
August 2005

Dose escalation trial designs based on a molecularly targeted endpoint.

Stat Med 2005 Jul;24(14):2171-81

Biometrics Research Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/sim.2102
Publisher Site
http://dx.doi.org/10.1002/sim.2102DOI Listing
July 2005

Identifying multiple changepoints in heterogeneous binary data with an application to molecular genetics.

Biostatistics 2004 Oct;5(4):515-29

Biometric Research Branch, National Cancer Institute, 6130 Executive Blvd, Room 8136, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/biostatistics/kxh005DOI Listing
October 2004

Practical midcourse sample size modification in clinical trials.

Control Clin Trials 2003 Feb;24(1):4-15

National Heart, Lung, and Blood Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
February 2003

The effect of digoxin on the quality of life in patients with heart failure.

J Card Fail 2003 Feb;9(1):4-12

New York University School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1054/jcaf.2003.7DOI Listing
February 2003

Innovative designs in behavioural trials.

Stat Med 2002 Oct;21(19):2981-9

Clinical Trials & Surveys Corporation, Suite 350, Village of Cross Keys, Baltimore, Maryland 21210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/sim.1302DOI Listing
October 2002

Parametric and semiparametric approaches to testing for seasonal trend in serial count data.

Biostatistics 2002 Jun;3(2):289-98

National Cancer Institute, 6130 Executive Blvd. MSC 7434, Bethesda, MD 20892-7434, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/biostatistics/3.2.289DOI Listing
June 2002